Breaking News
Get 40% Off 0
Join +750K new investors every month who copy stock picks from billionaire's portfolios Sign Up Free
Close

Scinai Immunotherapeutics Ltd ADR (SCNI)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Scinai's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
3.490 +0.670    +23.76%
14/06 - Closed. Currency in USD ( Disclaimer )
After Hours
3.400
-0.090
-2.579%
0:59:43 - Real-time Data
  • Volume: 1,400,387
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 2.670 - 4.330
Type:  Equity
Market:  United States
Scinai 3.490 +0.670 +23.76%

Scinai Company Profile

 
Read the Scinai Immunotherapeutics Ltd ADR company profile to learn more about the business and the management team. View Scinai Immunotherapeutics Ltd ADR facts about employee data, company products and services, and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

33

Equity Type

ADR

Scinai Immunotherapeutics Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases in Israel. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is headquartered in Jerusalem, Israel.

Contact Information

Address Jerusalem BioPark 2nd floor
Hadassah Ein Kerem Campus Jerusalem,
Israel
Phone 972 8 930 2529
Fax 972 8 930 2531

Top Executives

Name Age Since Title
Ruth Arnon 91 - Head of Scientific Advisory Board
Avner Rotman 81 2005 Independent Director
Morris C. Laster 59 2017 Independent Director
Michel Revel 86 - Member of Scientific Advisory Board
Samuel J. Moed 61 2020 Director
Matthias Dobbelstein - 2022 Member of Scientific Advisory Board
Amir Reichman 48 2021 CEO & Director
George H. Lowell 79 2008 Member of Scientific Advisory Board
Mark S. Germain 73 2018 Chairman of the Board
Yael Margolin 70 2020 Independent Director
Adi Raviv 68 2020 Independent Director
Jay Green 52 2021 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SCNI Price Commentary

Write your thoughts about Scinai Immunotherapeutics Ltd ADR
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email